206 related articles for article (PubMed ID: 6682376)
1. Metoclopramide. A review of antiemetic trials.
Gralla RJ
Drugs; 1983 Feb; 25 Suppl 1():63-73. PubMed ID: 6682376
[TBL] [Abstract][Full Text] [Related]
2. Efficacy & tolerability of ondansetron compared to metoclopramide in dose dependent cisplatin-induced delayed emesis.
Bhatia A; Tripathi KD; Sharma M
Indian J Med Res; 2004 Sep; 120(3):183-93. PubMed ID: 15489556
[TBL] [Abstract][Full Text] [Related]
3. Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy.
Bhatia A; Tripathi KD; Sharma M
Indian J Med Res; 2003 Jul; 118():33-41. PubMed ID: 14748464
[TBL] [Abstract][Full Text] [Related]
4. [Recent advances in the management of chemotherapy-induced emesis].
Murakami M; Ota K
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):401-11. PubMed ID: 3006594
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the antiemetic efficacy of prochlorperazine and metoclopramide for the treatment of cisplatin-induced emesis: a prospective, randomized, double-blind study.
Carr BI; Bertrand M; Browning S; Doroshow JH; Presant C; Pulone B; Hill LR
J Clin Oncol; 1985 Aug; 3(8):1127-32. PubMed ID: 4040552
[TBL] [Abstract][Full Text] [Related]
6. [Research on antiemetics: an Italian model of success].
Roila F
Tumori; 1998; 84(1 Suppl):S3-11. PubMed ID: 9617377
[TBL] [Abstract][Full Text] [Related]
7. Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Italian Group For Antiemetic Research.
Lancet; 1992 Jul; 340(8811):96-9. PubMed ID: 1352024
[TBL] [Abstract][Full Text] [Related]
8. Ondansetron: a pharmacoeconomic and quality-of-life evaluation of its antiemetic activity in patients receiving cancer chemotherapy.
Plosker GL; Milne RJ
Pharmacoeconomics; 1992 Oct; 2(4):285-304. PubMed ID: 10147044
[TBL] [Abstract][Full Text] [Related]
9. Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research.
Roila F; Tonato M; Basurto C; Picciafuoco M; Bracarda S; Donati D; Malacarne P; Monici L; Di Costanzo F; Patoia L
J Clin Oncol; 1989 Nov; 7(11):1693-700. PubMed ID: 2681556
[TBL] [Abstract][Full Text] [Related]
10. Effective control of moderate-dose cisplatin-induced emesis by a short-course regimen including metoclopramide, chlorpromazine and hydrocortisone: results of a randomized trial with metoclopramide alone.
Pollera CF; Calabresi F
Oncology; 1989; 46(4):238-44. PubMed ID: 2740067
[TBL] [Abstract][Full Text] [Related]
11. Double-blind crossover trial of droperidol, metoclopramide, and prochlorperazine as antiemetics in cisplatin therapy.
Lewis GO; Bernath AM; Ellison NM; Gallagher JG; Porter PA; Rine KT
Clin Pharm; 1984; 3(6):618-21. PubMed ID: 6391784
[TBL] [Abstract][Full Text] [Related]
12. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.
Gralla RJ; Itri LM; Pisko SE; Squillante AE; Kelsen DP; Braun DW; Bordin LA; Braun TJ; Young CW
N Engl J Med; 1981 Oct; 305(16):905-9. PubMed ID: 7024807
[TBL] [Abstract][Full Text] [Related]
13. Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover study.
Kenward H; Elliott J; Lee T; Pelligand L
BMC Vet Res; 2017 Aug; 13(1):244. PubMed ID: 28814338
[TBL] [Abstract][Full Text] [Related]
14. [A randomized controlled trial of acute and delayed cisplatin-induced emesis with metoclopramide, dexamethasone and prochlorperazine].
Nino S; Umehara H; Inoue I; Tamura T; Sasaki Y; Sakurai M; Shinkai T; Eguchi K; Saijo N; Suemasu K
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2881-4. PubMed ID: 3310905
[TBL] [Abstract][Full Text] [Related]
15. Ondansetron: a review of its use as an antiemetic in children.
Culy CR; Bhana N; Plosker GL
Paediatr Drugs; 2001; 3(6):441-79. PubMed ID: 11437189
[TBL] [Abstract][Full Text] [Related]
16. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
17. Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. The Italian Group for Antiemetic Research.
J Clin Oncol; 1997 Jan; 15(1):124-30. PubMed ID: 8996133
[TBL] [Abstract][Full Text] [Related]
18. Antiemetic efficacy of high-dose intravenous metoclopramide and dexamethasone in patients receiving cisplatin-based chemotherapy: a randomized controlled trial.
Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tamura T; Tominaga K; Sakurai M; Sano T; Taito H; Takahashi H
Jpn J Clin Oncol; 1986 Sep; 16(3):279-87. PubMed ID: 3534348
[TBL] [Abstract][Full Text] [Related]
19. Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients.
Kris MG; Gralla RJ; Tyson LB; Clark RA; Kelsen DP; Reilly LK; Groshen S; Bosl GJ; Kalman LA
Cancer; 1985 Feb; 55(3):527-34. PubMed ID: 3880660
[TBL] [Abstract][Full Text] [Related]
20. Improved benefit/risk ratio of higher-dose metoclopramide therapy during cisplatin-induced emesis.
Saller R; Hellenbrecht D; Hellstern A; Hess H
Eur J Clin Pharmacol; 1985; 29(3):311-2. PubMed ID: 4076327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
